88IV - PR Newswire Asia's news


Bambusa Therapeutics Appoints Todd James Chief Financial Officer - Mr. James brings more than 20 years of biopharmaceutical leadership experience, with deep expertise in capital markets, investor relations, and corporate strategy, serving in senior executive roles at ... 2026-03-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ractigen Therapeutics Announces China NMPA IND Approval for Phase II Clinical Trial of saRNA Therapy RAG-01 in Non-Muscle Invasive Bladder Cancer NANTONG, China , March 19, 2026 /PRNewswire/ -- Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced ... 2026-03-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Brii Biosciences Provides Corporate Updates and Reports Full Year 2025 Financial Results Advancing HBV Functional Cure Toward Key Phase 2b Data Readouts ... 2026-03-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China SHANGHAI , March 19, 2026 /PRNewswire/ -- Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical ... 2026-03-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI , March 19, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the ... 2026-03-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kelun-Biotech to Present the Final OS Analysis of Sacituzumab Tirumotecan (Sac-TMT) from the OptiTROP-Lung03 Study CHENGDU, China , March 18, 2026 /PRNewswire/ -- The 2026 European Lung Cancer Congress (ELCC) will be held in Copenhagen, Denmark, from March 25 to 28, 2026 (local time). At this congress, the final ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Alphamab Oncology Appoints Mr. Fei Wang as Chief Financial Officer SUZHOU, China , March 18, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced the appointment of Mr. Fei Wang as Chief Financial Officer (CFO). Mr. Wang will be responsible for ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support Largest-ever grant from RIGHT Foundation to accelerate Phase 1b clinical trial of RSV preventive antibody Technology licensed from Gates MRI; early studies confirm suppression of RSV infection ... 2026-03-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics The Atlas will expand known evolutionary genetic diversity by 100x, collecting novel genomic data from over 100 million new species across thousands of sites globally. By partnering with Anthropic, ... 2026-03-18T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
MVC's ENVACGEN® is Granted First Enterovirus A71 Vaccine Marketing Authorization in Vietnam; Joins Forces with Substipharm Biologics to Expand Southeast Asian Market TAIPEI and GENEVA , March 18, 2026 /PRNewswire/ -- Medigen Vaccine Biologics Corp. (MVC) and Substipharm Biologics announced on March 17 that ENVACGEN®, an Enterovirus 71 (EV-A71) vaccine, ... 2026-03-18T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology